Medical Innovation Exchange

02-MedTech Economics

Drivers and Implications of Multi-Billion Dollar Acquisitions in Medtech

Drivers and Implications of Multi-Billion Dollar Acquisitions in Medtech     After a busy 2021, medical technology (medtech) mergers and acquisitions (M&As) dropped in 2022 largely due to the impacts of COVID-19, rising inflation and supply chain challenges. But some medtech companies were able to launch megadeals in 2022 despite macroeconomic conditions.[1] While billion-dollar deals are …

Drivers and Implications of Multi-Billion Dollar Acquisitions in Medtech Read More »

A New Chapter in Digital Health Investing  

A New Chapter in Digital Health Investing       Before the COVID-19 pandemic, few digital health tools were used in care delivery, and only about a third of consumers had ever used live video telemedicine services.[1] The pandemic poured jet fuel on the digital health market as providers and health systems turned to digital tools …

A New Chapter in Digital Health Investing   Read More »

FDA Updates Breakthrough Devices Program Guidance

FDA Updates Breakthrough Devices Program Guidance     The FDA has issued an update to the final guidance: Breakthrough Devices Program. The updates are intended to clarify how the Breakthrough Devices Program applies to certain innovative medical devices that may address health inequities, as well as devices that may offer a non-addictive option to treat pain or …

FDA Updates Breakthrough Devices Program Guidance Read More »